Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q53296175 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000043.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q53296175 | ||
024 | ‡a 0000-0003-0098-0873 ‡2 orcid | ||
035 | ‡a (OCoLC)Q53296175 | ||
100 | 0 | ‡a Eun Kyung Lee ‡9 es ‡9 sl ‡9 ast | |
400 | 0 | ‡a Eun Kyung Lee ‡c researcher (ORCID 0000-0003-0098-0873) ‡9 en | |
400 | 0 | ‡a イ・ウンギョン ‡9 ja | |
400 | 0 | ‡a Eun Kyung Lee ‡c onderzoeker ‡9 nl | |
670 | ‡a Author's Acute Hyperglycemia Associated with Anti-Cancer Medication. | ||
670 | ‡a Author's Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. | ||
670 | ‡a Author's Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial. | ||
670 | ‡a Author's DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma | ||
670 | ‡a Author's Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer | ||
670 | ‡a Author's Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea. | ||
670 | ‡a Author's Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study | ||
670 | ‡a Author's Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.). | ||
670 | ‡a Author's Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study | ||
670 | ‡a Author's Natural Killer Cells and Thyroid Diseases | ||
670 | ‡a Author's Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. | ||
670 | ‡a Author's Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. | ||
670 | ‡a Author's Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. | ||
670 | ‡a Author's Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma | ||
670 | ‡a Author's Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro). | ||
670 | ‡a Author's The association of the BRAF | ||
670 | ‡a Author's The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. | ||
670 | ‡a Author's The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems | ||
670 | ‡a Author's The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer | ||
670 | ‡a Author's Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling. | ||
670 | ‡a Author's Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data | ||
670 | ‡a Author's Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery. | ||
909 | ‡a (orcid) 0000000300980873 ‡9 1 | ||
919 | ‡a polymorphismsofadipor1andadipor2areassociatedwithphenotypesoftype2diabetesinkoreans ‡A Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. ‡9 1 | ||
919 | ‡a naturalkillercellsandthyroiddiseases ‡A Natural Killer Cells and Thyroid Diseases ‡9 1 | ||
919 | ‡a acutehyperglycemiaassociatedwithanticancermedication ‡A Acute Hyperglycemia Associated with Anti-Cancer Medication. ‡9 1 | ||
919 | ‡a changesintheclinicopathologicalcharacteristicsandoutcomesofthyroidcancerinkoreaoverthepast4decades ‡A Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. ‡9 1 | ||
919 | ‡a longtermrecurrenceofsmallpapillarythyroidcanceranditsriskfactorsinakoreanmulticenterstudy ‡A Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study ‡9 1 | ||
919 | ‡a definingradioiodinerefractorydifferentiatedthyroidcancerefficacyandsafetyoflenvatinibbyradioiodinerefractorycriteriaintheselecttrial ‡A Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial. ‡9 1 | ||
919 | ‡a dnamethylationofmapksignalinhibitinggenesinpapillarythyroidcarcinoma ‡A DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma ‡9 1 | ||
919 | ‡a integrativeanalysisofgenomicandtranscriptomiccharacteristicsassociatedwithprogressionofaggressivethyroidcancer ‡A Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer ‡9 1 | ||
919 | ‡a interactionbetweenalcoholconsumptionandmethylenetetrahydrofolatereductasepolymorphismsinthyroidcancerrisknationalcancercentercohortinkorea ‡A Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea. ‡9 1 | ||
919 | ‡a lesionbasedevaluationpredictstreatmentresponsetolenvatinibforradioactiveiodinerefractorydifferentiatedthyroidcancerakoreanmulticenterretrospectivestudy ‡A Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study ‡9 1 | ||
919 | ‡a letterexpressionofglucagonlikepeptide1receptorinpapillarythyroidcarcinomaanditsclinicopathologicsignificanceendocrinolmetab20142953644minjungjungetal ‡A Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.). ‡9 1 | ||
919 | ‡a tumorsizeandagepredicttheriskofmalignancyinhurthlecellneoplasmofthethyroidandcanthereforeguidetheextentofinitialthyroidsurgery ‡A Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery. ‡9 1 | ||
919 | ‡a totalthyroidectomysassociationwithsurvivalinpapillarythyroidcancersandthehighproportionoftotalthyroidectomyinlowriskpatientsanalysisofkoreannationwidedata ‡A Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data ‡9 1 | ||
919 | ‡a therapeuticpotentialofdickkopf1inwildtypebrafpapillarythyroidcancerviaregulationofβcateninecadherinsignaling ‡A Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling. ‡9 1 | ||
919 | ‡a effectofexternalbeamradiotherapyvolumeonlocoregionalcontrolinpatientswithlocoregionallyadvancedorrecurrentnonanaplasticthyroidcancer ‡A The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer ‡9 1 | ||
919 | ‡a binarypresenceorabsenceoflymphnodemetastasisorextrathyroidalextensionisnotassociatedwithsurvivalinpapillarythyroidcancersimplicationsforstagingsystems ‡A The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems ‡9 1 | ||
919 | ‡a associationofthebrafv600emutationwithprognosticfactorsandpoorclinicaloutcomeinpapillarythyroidcancerametaanalysis ‡A The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. ‡9 1 | ||
919 | ‡a associationofthebraf ‡A The association of the BRAF ‡9 1 | ||
919 | ‡a studyprotocolofmulticenterprospectivecohortstudyofactivesurveillanceonpapillarythyroidmicrocarcinomamaestro ‡A Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro). ‡9 1 | ||
919 | ‡a studyprotocolofmulticenterprospectivecohortstudyofactivesurveillanceonpapillarythyroidmicrocarcinoma ‡A Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma ‡9 1 | ||
919 | ‡a riskfactorsforrecurrenceaftertherapeuticlateralneckdissectionforprimarypapillarythyroidcancer ‡A Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. ‡9 1 | ||
919 | ‡a postoperativesimultaneousintegratedboostintensitymodulatedradiationtherapyforpatientswithlocoregionallyadvancedpapillarythyroidcarcinomapreliminaryresultsofaphase2trialandpropensityscoreanalysis ‡A Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. ‡9 1 | ||
996 | ‡2 ISNI|0000000505543597 | ||
996 | ‡2 ISNI|0000000473836001 | ||
996 | ‡2 ISNI|0000000480112845 | ||
996 | ‡2 ISNI|0000000514765722 | ||
996 | ‡2 ISNI|0000000512350806 | ||
996 | ‡2 PLWABN|9814078486505606 | ||
996 | ‡2 ISNI|0000000475355260 | ||
996 | ‡2 ISNI|0000000474731631 | ||
996 | ‡2 ISNI|0000000461022182 | ||
996 | ‡2 ISNI|0000000049387358 | ||
996 | ‡2 ISNI|0000000502793873 | ||
996 | ‡2 SUDOC|067322867 | ||
996 | ‡2 ISNI|0000000475192051 | ||
996 | ‡2 ISNI|000000050844501X | ||
996 | ‡2 ISNI|0000000504866079 | ||
996 | ‡2 SUDOC|249033992 | ||
996 | ‡2 ISNI|0000000463358325 | ||
996 | ‡2 ISNI|0000000463229806 | ||
996 | ‡2 ISNI|0000000464692536 | ||
996 | ‡2 ISNI|0000000054535845 | ||
996 | ‡2 ISNI|0000000505550690 | ||
996 | ‡2 LC|n 2009023255 | ||
996 | ‡2 ISNI|0000000464364276 | ||
996 | ‡2 DNB|1048737373 | ||
996 | ‡2 ISNI|0000000483080199 | ||
996 | ‡2 ISNI|0000000473803912 | ||
996 | ‡2 ISNI|0000000492107752 | ||
996 | ‡2 ISNI|0000000468681885 | ||
996 | ‡2 ISNI|0000000463258797 | ||
996 | ‡2 DNB|1057645516 | ||
996 | ‡2 SUDOC|074302221 | ||
996 | ‡2 ISNI|0000000502716659 | ||
996 | ‡2 ISNI|0000000504168190 | ||
996 | ‡2 ISNI|0000000473935085 | ||
996 | ‡2 ISNI|0000000079897762 | ||
996 | ‡2 ISNI|0000000492274710 | ||
996 | ‡2 ISNI|0000000464895632 | ||
996 | ‡2 ISNI|0000000503961234 | ||
996 | ‡2 ISNI|0000000473365836 | ||
996 | ‡2 NLA|000035222926 | ||
996 | ‡2 NYNYRILM|49569 | ||
996 | ‡2 ISNI|0000000467920813 | ||
996 | ‡2 DNB|173044425 | ||
996 | ‡2 ISNI|0000000026172215 | ||
996 | ‡2 ISNI|0000000494000297 | ||
996 | ‡2 ISNI|0000000493264813 | ||
996 | ‡2 LC|no2005008552 | ||
996 | ‡2 ISNI|0000000509575190 | ||
996 | ‡2 ISNI|0000000479012273 | ||
996 | ‡2 ISNI|0000000464839956 | ||
996 | ‡2 ISNI|000000048394898X | ||
996 | ‡2 ISNI|0000000505750457 | ||
996 | ‡2 ISNI|0000000477367441 | ||
996 | ‡2 ISNI|0000000468670174 | ||
996 | ‡2 ISNI|0000000505366551 | ||
996 | ‡2 ISNI|000000051356438X | ||
996 | ‡2 ISNI|0000000477500476 | ||
996 | ‡2 ISNI|0000000473943624 | ||
996 | ‡2 ISNI|0000000513691792 | ||
996 | ‡2 NUKAT|n 2019201306 | ||
996 | ‡2 ISNI|0000000464520988 | ||
996 | ‡2 SUDOC|14790143X | ||
996 | ‡2 ISNI|0000000463596948 | ||
996 | ‡2 ISNI|000000050596640X | ||
996 | ‡2 ISNI|0000000464930813 | ||
996 | ‡2 ISNI|0000000508119177 | ||
996 | ‡2 ISNI|0000000513332968 | ||
996 | ‡2 LC|n 2022012875 | ||
996 | ‡2 ISNI|0000000489310573 | ||
996 | ‡2 ISNI|0000000504168377 | ||
996 | ‡2 ISNI|0000000468049687 | ||
996 | ‡2 LC|n 80047241 | ||
996 | ‡2 ISNI|0000000464444938 | ||
996 | ‡2 SUDOC|123241146 | ||
996 | ‡2 ISNI|0000000493179870 | ||
996 | ‡2 CAOONL|ncf11905477 | ||
996 | ‡2 ISNI|0000000479751869 | ||
996 | ‡2 ISNI|0000000494024280 | ||
996 | ‡2 ISNI|0000000479180891 | ||
996 | ‡2 JPG|500270361 | ||
996 | ‡2 ISNI|0000000473950883 | ||
996 | ‡2 ISNI|0000000513671118 | ||
996 | ‡2 DNB|1282670360 | ||
996 | ‡2 ISNI|0000000464782857 | ||
996 | ‡2 ISNI|0000000464921888 | ||
996 | ‡2 ISNI|0000000464301494 | ||
996 | ‡2 ISNI|0000000460992371 | ||
996 | ‡2 ISNI|0000000514768982 | ||
996 | ‡2 ISNI|0000000505548400 | ||
996 | ‡2 DNB|1167111788 | ||
996 | ‡2 ISNI|000000046779428X | ||
996 | ‡2 ISNI|0000000493140490 | ||
996 | ‡2 ISNI|0000000505548216 | ||
996 | ‡2 ISNI|000000046868199X | ||
996 | ‡2 LC|n 2014008067 | ||
996 | ‡2 ISNI|000000046805008X | ||
996 | ‡2 RERO|A023696252 | ||
996 | ‡2 ISNI|0000000492252423 | ||
996 | ‡2 ISNI|0000000514455337 | ||
996 | ‡2 LC|n 82004310 | ||
996 | ‡2 ISNI|0000000356720755 | ||
996 | ‡2 DNB|108056425X | ||
996 | ‡2 ISNI|0000000465052653 | ||
996 | ‡2 ISNI|0000000492001042 | ||
996 | ‡2 ISNI|0000000513683418 | ||
996 | ‡2 ISNI|0000000513202442 | ||
996 | ‡2 ISNI|000000051167450X | ||
996 | ‡2 ISNI|0000000431905179 | ||
996 | ‡2 LC|nb2012025485 | ||
996 | ‡2 ISNI|0000000504728944 | ||
996 | ‡2 ISNI|0000000480203077 | ||
996 | ‡2 ISNI|0000000513644865 | ||
996 | ‡2 ISNI|0000000480265534 | ||
996 | ‡2 ISNI|0000000473993015 | ||
996 | ‡2 ISNI|0000000479038668 | ||
996 | ‡2 ISNI|000000050494329X | ||
996 | ‡2 LC|n 2018070185 | ||
996 | ‡2 NII|DA09539631 | ||
996 | ‡2 ISNI|0000000473896135 | ||
996 | ‡2 DNB|128992964 | ||
996 | ‡2 ISNI|0000000473957129 | ||
996 | ‡2 ISNI|0000000464302737 | ||
996 | ‡2 ISNI|0000000512279245 | ||
996 | ‡2 ISNI|0000000478569109 | ||
996 | ‡2 SUDOC|111283450 | ||
996 | ‡2 ISNI|0000000463229718 | ||
996 | ‡2 ISNI|0000000480112968 | ||
996 | ‡2 ISNI|0000000483506372 | ||
996 | ‡2 ISNI|0000000493173137 | ||
996 | ‡2 ISNI|0000000513810923 | ||
996 | ‡2 ISNI|0000000504644732 | ||
996 | ‡2 ISNI|0000000512501416 | ||
996 | ‡2 ISNI|0000000512329409 | ||
996 | ‡2 ISNI|0000000504543552 | ||
996 | ‡2 ISNI|0000000463278042 | ||
996 | ‡2 ISNI|0000000463310970 | ||
996 | ‡2 ISNI|0000000480266019 | ||
996 | ‡2 SUDOC|169836630 | ||
996 | ‡2 J9U|987007403877905171 | ||
996 | ‡2 LC|nr 94043069 | ||
996 | ‡2 ISNI|0000000464774611 | ||
996 | ‡2 ISNI|0000000465111182 | ||
996 | ‡2 ISNI|0000000513360475 | ||
996 | ‡2 ISNI|0000000473885970 | ||
996 | ‡2 DNB|1038516552 | ||
996 | ‡2 ISNI|0000000480265745 | ||
996 | ‡2 NSK|000610670 | ||
996 | ‡2 ISNI|0000000465089771 | ||
996 | ‡2 ISNI|0000000514813149 | ||
996 | ‡2 ISNI|0000000504520801 | ||
996 | ‡2 ISNI|0000000514826580 | ||
996 | ‡2 LC|n 2024039224 | ||
996 | ‡2 ISNI|0000000512341109 | ||
996 | ‡2 ISNI|0000000479093405 | ||
996 | ‡2 ISNI|0000000473876169 | ||
996 | ‡2 ISNI|0000000480265964 | ||
996 | ‡2 ISNI|0000000492016658 | ||
996 | ‡2 ISNI|0000000513668322 | ||
996 | ‡2 ISNI|0000000505003566 | ||
996 | ‡2 ISNI|0000000479013858 | ||
996 | ‡2 ISNI|0000000494030170 | ||
996 | ‡2 DNB|139819940 | ||
996 | ‡2 ISNI|0000000468080721 | ||
996 | ‡2 ISNI|0000000510833417 | ||
996 | ‡2 ISNI|0000000463278034 | ||
996 | ‡2 BNF|16757788 | ||
996 | ‡2 DNB|1262899907 | ||
996 | ‡2 ISNI|0000000461102799 | ||
996 | ‡2 ISNI|0000000473795414 | ||
996 | ‡2 LC|no2003027039 | ||
996 | ‡2 ISNI|0000000516903316 | ||
996 | ‡2 ISNI|0000000443588908 | ||
996 | ‡2 ISNI|0000000480265999 | ||
996 | ‡2 ISNI|0000000503957227 | ||
996 | ‡2 ISNI|0000000473912860 | ||
996 | ‡2 ISNI|0000000467821313 | ||
996 | ‡2 ISNI|0000000508394603 | ||
996 | ‡2 ISNI|0000000493211287 | ||
996 | ‡2 NTA|30436620X | ||
996 | ‡2 ISNI|0000000504198963 | ||
996 | ‡2 DNB|1257278401 | ||
996 | ‡2 ISNI|0000000493179838 | ||
996 | ‡2 ISNI|0000000479284850 | ||
996 | ‡2 ISNI|0000000505550359 | ||
996 | ‡2 LC|n 2024184814 | ||
996 | ‡2 J9U|987007462550205171 | ||
996 | ‡2 ISNI|0000000505733120 | ||
996 | ‡2 ISNI|0000000473972695 | ||
996 | ‡2 ISNI|0000000475122360 | ||
996 | ‡2 LC|no2011069902 | ||
996 | ‡2 ISNI|0000000473872379 | ||
996 | ‡2 ISNI|000000049249027X | ||
996 | ‡2 NTA|146942388 | ||
996 | ‡2 ISNI|0000000472525981 | ||
996 | ‡2 ISNI|0000000464594661 | ||
996 | ‡2 ISNI|0000000465016679 | ||
996 | ‡2 DE633|pe30101248 | ||
996 | ‡2 ISNI|0000000513463618 | ||
996 | ‡2 ISNI|0000000504218637 | ||
996 | ‡2 ISNI|0000000053432940 | ||
996 | ‡2 ISNI|0000000477193701 | ||
996 | ‡2 BNF|13519115 | ||
996 | ‡2 ISNI|0000000474751261 | ||
996 | ‡2 LC|no2017129977 | ||
996 | ‡2 ISNI|0000000473807868 | ||
996 | ‡2 ISNI|0000000475201755 | ||
996 | ‡2 ISNI|0000000516825098 | ||
996 | ‡2 ISNI|0000000474158601 | ||
996 | ‡2 ISNI|0000000467789501 | ||
996 | ‡2 ISNI|0000000473797006 | ||
996 | ‡2 BIBSYS|90960393 | ||
996 | ‡2 ISNI|0000000474065667 | ||
996 | ‡2 ISNI|0000000463248812 | ||
996 | ‡2 ISNI|0000000503938018 | ||
996 | ‡2 ISNI|0000000464268639 | ||
996 | ‡2 BNF|16666677 | ||
996 | ‡2 ISNI|000000046865801X | ||
996 | ‡2 ISNI|0000000474200371 | ||
996 | ‡2 ISNI|0000000460977956 | ||
996 | ‡2 ISNI|0000000505576989 | ||
996 | ‡2 ISNI|0000000464673810 | ||
996 | ‡2 ISNI|0000000464444727 | ||
996 | ‡2 ISNI|0000000050173736 | ||
996 | ‡2 ISNI|000000046791443X | ||
996 | ‡2 ISNI|0000000503936522 | ||
996 | ‡2 ISNI|0000000492337136 | ||
996 | ‡2 ISNI|0000000505936593 | ||
996 | ‡2 NII|DA03801254 | ||
996 | ‡2 NLR|RU NLR AUTH 770180422 | ||
996 | ‡2 ISNI|0000000464594864 | ||
996 | ‡2 ISNI|000000046443772X | ||
996 | ‡2 DNB|1156978726 | ||
996 | ‡2 ISNI|0000000473957161 | ||
996 | ‡2 ISNI|0000000472426131 | ||
996 | ‡2 DNB|1052913202 | ||
996 | ‡2 ISNI|0000000464269367 | ||
996 | ‡2 ISNI|0000000494068339 | ||
996 | ‡2 ISNI|0000000512283025 | ||
996 | ‡2 ISNI|0000000512522858 | ||
996 | ‡2 ISNI|0000000465138721 | ||
996 | ‡2 ISNI|0000000463277787 | ||
996 | ‡2 ISNI|0000000516832925 | ||
996 | ‡2 ISNI|000000050526183X | ||
996 | ‡2 BNF|16217116 | ||
996 | ‡2 ISNI|0000000479075450 | ||
996 | ‡2 ISNI|0000000492376522 | ||
996 | ‡2 ISNI|0000000473895175 | ||
996 | ‡2 ISNI|0000000473803453 | ||
996 | ‡2 ISNI|0000000464595154 | ||
996 | ‡2 ISNI|0000000430576537 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |